Call to action short film featuring policymakers, NGO and PAG leaders on why it’s time to Speak Up for COPD.
Why Speak Up for COPD Video (2023)
Page: Chronic respiratory diseases
The role of the pharmacist in Chronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease that requires comprehensive care. Pharmacists have a role to play in the prevention, care and management of COPD. This event aims to highlight the key role of the pharmacist in COPD by providing insights into medication optimisation, inhaler technique and patient counselling. Participants will also learn about the COPD Right Care programme, a global social movement initiated by the International Primary Care Respiratory Group (IPCRG) to improve care for people with COPD, and also the Speak Up for COPD campaign, which aims to raise awareness and understanding of COPD among health and policy makers by amplifying the voices of patients, the COPD community and the public.
Moderator:
– Ema Paulino, President National Pharmacy Association (ANF), Portugal
Panellist:
– Tonya Winders, President & acting CEO of the Global Allergy & Airways Patient Platform (GAAPP); Chair of Speak Up for COPD, USA
– Siân Williams, Chief Executive Officer, International Primary Care Respiratory Group (IPCRG), Registered in Scotland, working internationally
– Darush Attar-Zadeh, Clinical Fellow Respiratory Pharmacist North West London Integrated Care Board, RightBreathe, United Kingdom (England)
– Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, The Netherlands
Speak Up for COPD – Video of the campaign
Speak Up for COPD is a coalition of advocates, clinicians and industry partners united in a common goal to bring urgent attention to the impact of COPD and establish it as a public health priority.
Through our work, we are calling for wider recognition of the societal and economic impact of COPD and to advance policies that effectively address its growing burden across the world.
We are speaking up to amplify the voices of people living with COPD, who frequently face stigma associated with smoking, as well as other socioeconomic factors, that may minimise the strength of their own voices.
Greater recognition of the impact of COPD is needed amongst healthcare providers to achieve better standards of care, which includes a holistic approach with improved access to effective treatments.
Speak Up for COPD
The Speak up for COPD campaign is intended to raise awareness and understanding of COPD amongst policymakers and healthcare decision makers by amplifying the voices of patients, the COPD community and the public. Our one critical goal is to establish COPD as a public health priority.
Making COPD a public health priority starts here: understanding the condition
Chronic obstructive pulmonary disease (COPD) is an increasingly important threat to the public and health systems around the world, yet is often overlooked as a significant public health issue.
It is time to make COPD a public health priority – A call to action for COPD, a silent epidemic that needs global attention urgently.
Understanding Chronic Obstructive Pulmonary Disease (COPD)
The “Breathe in the truth about COPD” infographic serves as a powerful call to action, spotlighting the urgent need for heightened awareness and prioritization of Chronic Obstructive Pulmonary Disease (COPD). COPD, a pervasive health concern, indiscriminately affects individuals of all ages and socioeconomic backgrounds across the globe.
Despite its widespread impact, COPD often finds itself in the shadows – under-prioritized, underfunded, and undertreated. This is particularly true among socioeconomically disadvantaged populations and countries, where the disease burden is most heavily felt.
This infographic is the product of a dedicated multi-stakeholder campaign coalition, Speak Up for COPD, consisting of advocacy and industry partners, united in the mission to amplify the voices of patients and the COPD community. By engaging policymakers and healthcare decision-makers, we strive to shape a future where COPD receives the critical attention it deserves.
Join us in this important cause and help us breathe new life into the fight against COPD.
Supporting tobacco cessation and the treatment of tobacco dependence: A handbook for pharmacists (2023)
This handbook has been developed as a comprehensive and practical resource for pharmacists to support individuals in their efforts to quit tobacco, emphasising the critical role of pharmacists in providing comprehensive and coordinated care to patients seeking to quit. It covers the latest evidence-based practices, techniques and strategies to help our patients quit and not start again. The information contained in this handbook is practicable and tailored to the needs of pharmacists working in the field. By using the information and strategies outlined in the handbook, pharmacists can contribute to improving public health and reducing the burden of tobacco use on healthcare systems.
This publication is available in the following languages:
Transforming pharmacy practice for improved care and management of chronic respiratory diseases
Asthma and chronic obstructive pulmonary disease are common chronic respiratory diseases (CRD) that affect millions of people worldwide. Pharmacists have a role to play in the prevention, care and management of CRD. FIP will be publishing a new handbook to support pharmacists and their organisations in providing a range of CRD-related services. This will be accompanied by a reference guide which identifies the knowledge and skills that pharmacists require for the provision of such services. Both publications will be launched at this event, and they are part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
Chronic respiratory diseases: A handbook for pharmacists (2022)
The United Nations Sustainable Development Goals prioritise universal health coverage (UHC) and commit to reducing the impact of non-communicable diseases (NCDs) as well as communicable diseases. This handbook is an important enabling tool to achieve those goals because it makes the case for the inclusion of care for chronic respiratory diseases (CRDs) as part of UHC and demonstrates the important role pharmacists have in achieving this.
